Poland· PL-100472075
Neorelium
A diazepam product containing diazepamum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Diazepam is registered in 18 of 19 countries.
Countries holding a registration under ATC N05BA01 (diazepam), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Diazepam · ATC N05BA01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of diazepam costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.048 in France to $0.92 in Switzerland — a ×19 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Diazepam · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.92
- ES Spain$0.11
- FR France$0.048
The record
At a glance
URPL (Poland)- Active substance
- Diazepamum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N05BA01
- ATC class
- Diazepam
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991492960
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
460 interactions on record for diazepam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diazepam · interactions on record
460 records
- 4 severe
- 147 moderate
- 35 minor
- 222 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
52 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N05BA01
Diazepam, as other registers publish it.
- IrelandAnxicalm 10 mg TabletsClonmel Healthcare Ltd
- IrelandAnxicalm 2 mg TabletsClonmel Healthcare Ltd
- IrelandAnxicalm 5 mg TabletsClonmel Healthcare Ltd
- CzechiaAPAURINKrka, d.d., Novo mesto, Novo mesto
- FinlandApozepamAlpharma A/S
- DenmarkApozepamTeva B.V.
- FinlandApozepamAlpharma A/S
- FinlandApozepamAlpharma A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dba84037-237c-4521-91f8-f78c4df9964e GET /v1/drugs/dba84037-237c-4521-91f8-f78c4df9964e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909991492960 ¦ Rp ¦ 146342\n20 tabl.",
"substance": "Diazepamum 5 mg",
"common_name": "Diazepamum",
"pl_product_id": "100472075",
"pozwolenie_nr": "297/22",
"auth_procedure": "IR",
"authorisation_validity": "2027-08-03"
}See everything about diazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.